Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't some cure-all.

Add Yahoo as a preferred source to see more of our stories on Google. Jack Welter didn’t feel sick when he agreed to take a new blood test that looks for multiple types of cancer. But, approaching 60, ...

GRAIL IS AN American biotech company with an ambitious goal: to develop a blood test for the early detection of over 50 types of cancer. It will not be easy. On February 19th the company announced ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian ...

RICHMOND, Va. — A relatively new blood test could transform how cancer is detected, potentially identifying 10 different types of cancer with a single test. "This is something I and many of my ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...